MedBioSphere
Articles Videos The Web  
    

A multicentre randomized double

Selected Abstract

A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.(WASHINGTON WHISPERS)
A Multicentre, Randomized, Double-Blind, Controlled Study of Long-Term Treatment with 0.1% Tacrolimus Ointment in Adults with Moderate to Severe Atopic Dermatitis Reitamo S, et al. British Journal of Dermatology. 2005; 152:1282-1289. Summary The authors present a randomized, double-blind, ...
September 1, 2005; Journal of Drugs in Dermatology

Read the full article with a free-trial membership at HighBeam Research



Related Articles

1. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.(WASHINGTON WHISPERS)
2. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.(Recent Abstracts)(Brief article)(Clinical report)
3. WEX Starts Phase III Trial of Tectin(TM) for Cancer Pain
4. WEX Starts Phase III Trial of Tectin(TM) for Cancer Pain.
5. Schering Completes BENEFIT Study in Early Multiple Sclerosis.
6. WEX Announces Presentation at Scientific Conference
7. WEX Announces Presentation at Scientific Conference.(Conference news)
8. International Wex Technologies Inc.: Pivotal Phase IIb/III Trial of Tectin(TM) for Cancer Pain Begins.
9. McMaster University: Cure Study Results Published in the New England Journal Of Medicine and the Lancet Show Benefit of Clopidogrel in Patients with Acute Coronary Syndrome.
10. WEX Appoints Chief Financial Officer.